Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 2

Sponsor Class

OTHER_GOV 2

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Sarcoma 2Gastrointestinal 1

Conditions

Neoplasms 5Colorectal Neoplasms, Hereditary Nonpolyposis 3Colorectal Neoplasms 3Sarcoma 2Recurrence 2Carcinoma, Non-Small-Cell Lung 2Breast Neoplasms 2Stage IIIb and IV Non Small Cell Lung Cancer 1Solid Tumor, Adult 1Rare Diseases 1Prostatic Neoplasms 1Ovarian Neoplasms 1Neuroblastoma 1Neoplastic Syndromes, Hereditary 1Neoplasm, Residual 1Neoplasm Metastasis 1Multiple Myeloma 1Mouth Neoplasms 1Microsatellite Instability 1Lymphoma, Non-Hodgkin 1Lung Neoplasms 1Leukemia, Myelogenous, Chronic, BCR-ABL Positive 1Hereditary Breast and Ovarian Cancer Syndrome 1Head and Neck Neoplasms 1Genetic Predisposition to Disease 1Colonic Neoplasms 1Carcinoma, Transitional Cell 1Carcinoma, Medullary 1COVID-19 1Biliary Tract Neoplasms 1

Interventions

Doxorubicin 142Ifosfamide 85Radiotherapy 82Cyclophosphamide 72Gemcitabine 63Filgrastim 54pembrolizumab 43pazopanib 40Etoposide 39Docetaxel 39Vincristine 37Trabectedin 37Cisplatin 35Nivolumab 32Magnetic Resonance Spectroscopy 26Irinotecan 26Carboplatin 25Temozolomide 23Surgical Procedures, Operative 23Radiation 22Ipilimumab 22Bevacizumab 20Blood Specimen Collection 19Granulocyte Colony-Stimulating Factor 18Biopsy 18eribulin 17Sirolimus 17Mesna 17Melphalan 17Dactinomycin 17

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Sarcoma × High-Throughput Nucleotide Sequencing × Clear all
NCT03784014 2026-04-29

MULTISARC

Institut National de la Santé Et de la Recherche Médicale, France

Phase 3 Completed
603 enrolled
Sarcoma

Neoplasm Metastasis, Sarcoma

NCT03546127 2025-09-11

MULTIPLI-0

Institut National de la Santé Et de la Recherche Médicale, France

Completed
24 enrolled
GastrointestinalSarcoma

Sarcoma, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡